renal cancer

Showing 1 posts of 1 posts found.


Bristol-Myers Squibb demonstrates potential for long-term survival in kidney cancer patients treated with Opdivo plus Yervoy

February 20, 2020
Business Services Cancer, Cancers, Yervoy, opdivo, renacl cell carcinoma, renal cancer

Bristol-Myers Squibb has announced updated results from trialing Opdivo (nivolumab) plus Yervoy (ipilimumab) versus sunitinib in patients with previously untreated …

Latest content